Skip to main navigation Skip to search Skip to main content

Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles

  • International Headache Genetics Consortium
  • , HUNT All-in Headache
  • , Danish Blood Donor Study Genomic Cohort
  • University of Helsinki
  • University of Oslo
  • Norwegian University of Science and Technology
  • deCODE Genetics
  • Leiden University
  • University of Copenhagen
  • GlaxoSmithKline
  • Helsinki University Hospital
  • Laeknasetrid
  • Vrije Universiteit Amsterdam
  • Brigham and Women’s Hospital
  • Harvard University
  • Ludwig Maximilian University of Munich
  • Munich Cluster for Systems Neurology (SyNergy)
  • Aarhus University
  • Erasmus University Rotterdam
  • Landspitali University Hospital
  • Tampere University
  • Charité – Universitätsmedizin Berlin
  • Sjællands Universitetshospital
  • GGZ inGeest Specialized Mental Health Care
  • Karolinska Institutet
  • National Institute for Health and Welfare
  • Klinikum Passau
  • University of Tübingen
  • Imperial College London
  • University of Oulu
  • Brunel University London
  • University of Turku
  • Folkhalsan
  • Queensland University of Technology
  • Broad Institute
  • Massachusetts General Hospital

Research output: Contribution to journalArticlepeer-review

Abstract

Migraine affects over a billion individuals worldwide but its genetic underpinning remains largely unknown. Here, we performed a genome-wide association study of 102,084 migraine cases and 771,257 controls and identified 123 loci, of which 86 are previously unknown. These loci provide an opportunity to evaluate shared and distinct genetic components in the two main migraine subtypes: migraine with aura and migraine without aura. Stratification of the risk loci using 29,679 cases with subtype information indicated three risk variants that seem specific for migraine with aura (in HMOX2, CACNA1A and MPPED2), two that seem specific for migraine without aura (near SPINK2 and near FECH) and nine that increase susceptibility for migraine regardless of subtype. The new risk loci include genes encoding recent migraine-specific drug targets, namely calcitonin gene-related peptide (CALCA/CALCB) and serotonin 1F receptor (HTR1F). Overall, genomic annotations among migraine-associated variants were enriched in both vascular and central nervous system tissue/cell types, supporting unequivocally that neurovascular mechanisms underlie migraine pathophysiology.

Original languageEnglish
Pages (from-to)152-160
Number of pages9
JournalNature Genetics
Volume54
Issue number2
DOIs
Publication statusPublished - Feb 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles'. Together they form a unique fingerprint.

Cite this